The global veterinary point of care (POC) diagnostics market is experiencing significant growth as veterinary professionals increasingly adopt rapid diagnostic technologies to improve animal healthcare. According to Fortune Business Insights, the global veterinary point of care diagnostics market size was valued at USD 624.75 million in 2025 and is projected to grow from USD 680.76 million in 2026 to USD 1,353.11 million by 2034, exhibiting a CAGR of 8.97% during the forecast period.
The growing adoption of companion animals, increasing awareness of animal health, rising livestock production, and technological advancements in diagnostic devices are major factors driving market expansion. Point-of-care diagnostics enable veterinarians to obtain accurate test results within minutes, allowing faster treatment decisions and improved patient outcomes.
Note: The figures are typically reported in millions (USD million) for this market. If your source states USD 624.75 billion, it is likely a typographical error.
What are Veterinary Point of Care Diagnostics?
Veterinary point-of-care diagnostics refer to medical tests performed directly at veterinary clinics, animal hospitals, farms, or field locations rather than centralized laboratories. These diagnostic tools provide immediate results, enabling veterinarians to diagnose diseases quickly and begin treatment without delays.
Common point-of-care diagnostic tests include:
- Blood chemistry analysis
- Hematology testing
- Urinalysis
- Infectious disease testing
- Glucose monitoring
- Pregnancy testing
- Immunoassays
- Molecular diagnostics
These systems improve clinical efficiency while reducing turnaround time and laboratory dependency.
Market Growth Drivers
Rising Pet Ownership Worldwide
The increasing adoption of dogs, cats, and other companion animals has significantly boosted spending on veterinary healthcare. Pet owners are becoming more willing to invest in preventive healthcare, routine screening, and early disease detection, increasing demand for rapid diagnostic solutions.
Growing Awareness of Animal Health
Governments, veterinarians, and animal welfare organizations are promoting preventive healthcare and early diagnosis to reduce disease outbreaks. Point-of-care diagnostics support regular health monitoring for both companion and livestock animals.
Expansion of Livestock Industry
The global demand for meat, dairy, and poultry products continues to rise. Livestock producers increasingly utilize rapid diagnostic testing to detect infectious diseases early, ensuring animal health and minimizing economic losses.
Technological Advancements
Modern veterinary diagnostic devices are becoming smaller, faster, and more accurate. Portable analyzers, AI-assisted diagnostic software, cloud connectivity, and digital imaging technologies are transforming veterinary practice and improving diagnostic accuracy.
Emerging Market Trends
Portable Diagnostic Devices
Portable and handheld diagnostic systems are gaining popularity because they allow veterinarians to perform tests during farm visits, emergency care, and remote veterinary services.
Artificial Intelligence Integration
Artificial intelligence is increasingly being integrated into veterinary diagnostic platforms. AI helps interpret test results, identify disease patterns, and support clinical decision-making with greater accuracy.
Telemedicine and Digital Healthcare
The growing adoption of telemedicine in veterinary care has increased demand for rapid diagnostics that generate immediate results. Combined with cloud-based platforms, veterinarians can remotely review patient data and recommend treatments efficiently.
Molecular Diagnostics
Rapid molecular testing is becoming more common for detecting infectious diseases in animals. These advanced diagnostic methods provide high sensitivity and specificity while reducing diagnostic time.
Market Challenges
Despite favorable growth prospects, the veterinary point-of-care diagnostics market faces several challenges.
The relatively high cost of advanced diagnostic equipment may limit adoption among small veterinary clinics and rural healthcare providers. Additionally, some diagnostic devices require trained personnel for accurate operation and interpretation.
Regulatory compliance and quality assurance also present challenges for manufacturers seeking approval across multiple international markets.
Furthermore, limited veterinary healthcare infrastructure in developing countries can restrict market penetration despite growing demand.
Regional Outlook
North America
North America dominates the veterinary point-of-care diagnostics market due to high pet ownership, advanced veterinary infrastructure, and strong spending on companion animal healthcare. The presence of leading diagnostic manufacturers further supports regional growth.
Europe
Europe represents a mature market with increasing investments in animal welfare, preventive healthcare, and livestock disease management. Government regulations promoting animal health continue to drive diagnostic adoption.
Asia-Pacific
Asia-Pacific is expected to register the fastest growth during the forecast period. Rising disposable income, expanding livestock farming, increasing pet adoption, and improving veterinary healthcare infrastructure are contributing to market expansion across China, India, Japan, and Southeast Asia.
Latin America and Middle East & Africa
These regions are gradually strengthening veterinary healthcare services through improved livestock management and increased awareness of disease prevention, creating new opportunities for diagnostic solution providers.
Competitive Landscape
The global veterinary point-of-care diagnostics market is highly competitive, with leading companies focusing on product innovation, acquisitions, and expanding their diagnostic portfolios.
Major companies operating in the market include:
- IDEXX Laboratories, Inc.
- Zoetis Inc.
- Heska Corporation
- Abaxis
- Virbac
- Randox Laboratories
- Mindray Animal Medical
- Others
These companies continue investing in research and development to introduce faster, more accurate, and user-friendly diagnostic platforms that enhance veterinary care.
Future Opportunities
Several emerging trends are expected to create new opportunities in the veterinary point-of-care diagnostics market.
The increasing adoption of wearable animal health monitoring devices, AI-powered diagnostic software, portable molecular testing, and cloud-connected diagnostic platforms will significantly improve disease detection and patient management.
Growing investments in livestock disease surveillance programs and preventive veterinary medicine are also expected to increase demand for rapid diagnostic solutions worldwide.
Additionally, expanding veterinary telehealth services will further encourage the adoption of portable diagnostic devices that provide immediate clinical results.
Get Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-point-of-care-diagnostics-market-100362
Conclusion
The global veterinary point-of-care diagnostics market is poised for strong growth as the demand for rapid, accurate, and portable diagnostic solutions continues to rise. According to Fortune Business Insights, the market is projected to grow from USD 680.76 million in 2026 to USD 1,353.11 million by 2034, registering a CAGR of 8.97% during the forecast period.
Increasing pet ownership, expanding livestock production, technological advancements, and rising awareness of preventive animal healthcare are driving market expansion. Leading companies such as IDEXX Laboratories, Zoetis, Heska Corporation, Virbac, Randox Laboratories, and Mindray Animal Medical continue to innovate with advanced diagnostic technologies that improve veterinary care and clinical efficiency.
As veterinary medicine embraces digital transformation and precision diagnostics, point-of-care testing will remain an essential component of modern animal healthcare, supporting faster diagnoses, improved treatment outcomes, and enhanced animal well-being worldwide.
Contact Information
Fortune Business Insights™ Pvt. Ltd.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: [email protected]